Print Page  Close Window
8-K
PARATEK PHARMACEUTICALS, INC. filed this Form 8-K on 01/04/2019
Entire Document
 

Slide 32

NUZYRA Efficacy and Safety in ABSSSI and CABP Positive Benefit / Risk Profile